Top Markets
#1 Nesa Nesa +806.10%
#2 Cortex Cortex +69.01%
#3 Merlin's Seal BTC Merlin's Seal BTC +45.67%
#4 QuantixAI QuantixAI +24.54%
#5 Instadapp Instadapp +23.85%
#6 EXOD EXOD +22.78%
#7 Pons Pons +20.14%
#8 Cash Cat Cash Cat +12.38%
#9 PondCoin PondCoin +12.04%
#10 Fartcoin Fartcoin +11.87%
Coin of the day
Nesa Nesa
Configurações
Idioma
PORTUGUêS
Moeda
USD
Tema
Connect Biopharma Holdings Limited Connect Biopharma Holdings Limited

Connect Biopharma Holdings Limited

CNTB
Classificação em ações #19725
Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical... Connect Biopharma Holdings Limited is a clinical-stage biopharmaceutical company dedicated to discovering and advancing immune modulators. Its primary objective is to develop treatments for serious autoimmune diseases and various inflammatory conditions. The company's lead investigational therapy is CBP-201, an anti-interleukin-4 receptor alpha antibody. This candidate is currently in Phase IIb clinical trials, targeting inflammatory allergic diseases such as atopic dermatitis, asthma, and chronic rhinosinusitis with nasal polyps. Additionally, Connect Biopharma's pipeline includes CBP-307, a small molecule designed to modulate sphingosine 1-phosphate receptor 1. This receptor plays a crucial role in regulating T cell movement from lymph nodes into the bloodstream. CBP-307 is in Phase II development for treating autoimmune-related inflammatory disorders. Another preclinical-stage asset, CBP-174, is an orally administered small molecule histamine receptor 3 antagonist, being investigated for chronic pruritus (itch) associated with skin inflammation. The portfolio also features CBP-233, a humanized antibody in preclinical development that targets interleukin-33, a cytokine recognized for its involvement in T helper 2 inflammation. Established in 2012, the company maintains its headquarters in Taicang, China.
Preço da ação
$2.42
Última sincronização: 2026-08-25
Valor de mercado
$152.37M
Variação (1 dia)
5.22%
Variação (1 ano)
39.88%
País
US
Negociar Connect Biopharma Holdings Limited (CNTB)

Categoria

Healthcare
Histórico de preços das ações de Connect Biopharma Holdings Limited (CNTB)
Preço de fecho mais alto: $2.35 em 2026-08-01

Preço de fecho mais baixo: $17.02 em 2021-03-01
Histórico de preços das ações da Connect Biopharma Holdings Limited de 2021 a 2026
Desempenho anual do preço das ações
Ano Desempenho
2026 (TTM) -8.60%
2025 129.78%
2024 18.63%
2023 21.12%
2022 -83.36%
2021 0.00%
Preço das ações de empresas similares ou concorrentes
Empresa Preço da ação Variação 1a% País
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $553.09 42.85%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.02K 44.02%
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $158.64 541.49%
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.32 -12.49%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $772.27 7.33%
CH